Astroglial and Neuronal Injury Markers (GFAP, UCHL-1, NfL, Tau, S100B) as Diagnostic and Prognostic Biomarkers in PTSD and Neurological Disorders
International Journal of Molecular Sciences · 04.03.2026 · 27 (5) · 2374
DOI: 10.3390/ijms27052374 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.03.2026. Verfasst von Ewa Alicja Ogłodek und 1 weiteren Autor:innen. Beteiligte Einrichtung: Collegium Medicum, Jan Dlugosz University in Częstochowa, Waszyngtona 4/8 Street, 42-200 Częstochowa, Poland. Hauptthemen laut MEDLINE: Biomarkers, Astrocytes, Stress Disorders, Post-Traumatic, Neurons. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Post-traumatic stress disorder (PTSD) is increasingly recognized as a neurobiological condition involving persistent neuroinflammation, glial dysfunction, and neuronal injury. Chronic stress induces dysregulation of the hypothalamic–pituitary–adrenal axis, mitochondrial impairment, oxidative stress, and activation of inflammatory signaling pathways, leading to blood–brain barrier (BBB) disruption and progressive neural damage. These processes are reflected in circulating biomarkers that provide insight into underlying molecular pathology. This article focuses on key astroglial and neuronal injury markers—glial fibrillary acidic protein (GFAP), ubiquitin C-terminal hydrolase L1 (UCHL-1), neurofilament light chain (NfL), tau protein, and S100B—as indicators of stress-related brain dysfunction in PTSD. GFAP and S100B reflect astrocyte activation and BBB permeability, while UCHL-1, NfL, and tau indicate neuronal injury, axonal degeneration, and cytoskeletal instability. Accumulating clinical and experimental evidence suggests that altered levels of these biomarkers are associated with symptom severity, cognitive impairment, and neuroinflammatory activity in PTSD, often overlapping with mechanisms observed in neurodegenerative disorders. This review summarizes the current understanding of the biological significance and clinical relevance of these biomarkers and highlights their potential utility for early diagnosis, disease monitoring, and risk stratification. The combined assessment of astroglial and neuronal markers may support a more precise, biologically grounded approach to PTSD and facilitate the development of personalized diagnostic and therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Collegium Medicum, Jan Dlugosz University in Częstochowa, Waszyngtona 4/8 Street, 42-200 Częstochowa, Poland.
- Department of Clinical Neuroscience, Faculty of Medicine, University of Ostrava, 17. Listopadu 1790, 708 52 Ostrava, Czech Republic.
ORCID-Profile: Ewa Alicja Ogłodek
Zitieren
APA
Ogłodek, E. A., & Bar, M. (2026). Astroglial and Neuronal Injury Markers (GFAP, UCHL-1, NfL, Tau, S100B) as Diagnostic and Prognostic Biomarkers in PTSD and Neurological Disorders. International Journal of Molecular Sciences, 27(5), 2374. https://doi.org/10.3390/ijms27052374
Vancouver
Ogłodek EA, Bar M. Astroglial and Neuronal Injury Markers (GFAP, UCHL-1, NfL, Tau, S100B) as Diagnostic and Prognostic Biomarkers in PTSD and Neurological Disorders. International Journal of Molecular Sciences. 2026;27(5):2374. doi:10.3390/ijms27052374
BibTeX
@article{Ogodek2026,
author = {Ogłodek, Ewa Alicja and Bar, Michal},
title = {Astroglial and Neuronal Injury Markers (GFAP, UCHL-1, NfL, Tau, S100B) as Diagnostic and Prognostic Biomarkers in PTSD and Neurological Disorders},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {5},
pages = {2374},
doi = {10.3390/ijms27052374}
}
EUVIMED